Market Cap 72.67M
Revenue (ttm) 44.52M
Net Income (ttm) -2.84M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6.38%
Debt to Equity Ratio 0.25
Volume 116,800
Avg Vol 1,186,570
Day's Range N/A - N/A
Shares Out 14.98M
Stochastic %K 95%
Beta -0.06
Analysts Strong Buy
Price Target $8.50

Company Profile

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy tr...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 615 255 0068
Fax: 615 255 0094
Address:
1600 West End Avenue, Suite 1300, Nashville, United States
PrayTradeRepeat
PrayTradeRepeat May. 15 at 3:08 PM
$CPIX LET IT SQUEEZE.
0 · Reply
PrayTradeRepeat
PrayTradeRepeat May. 15 at 3:07 PM
0 · Reply
PrayTradeRepeat
PrayTradeRepeat May. 15 at 3:00 PM
$CPIX This does not look like a chart that is collapsing into the holiday weekend right now. What I would personally do in your position: Hold for now Do not add Do not panic dump Stay very focused on VWAP and 5.00 The key is how it behaves if sellers finally show up. If CPIX: loses 5.00 hard cannot reclaim VWAP starts printing expanding red candles with volume Then I would reduce risk quickly because holiday selling could accelerate. But if it: keeps holding 5.09-5.10 keeps squeezing slowly upward stays tight Then the path toward 5.30-5.50 is still alive.
0 · Reply
PrayTradeRepeat
PrayTradeRepeat May. 15 at 2:58 PM
$CPIX H O L D !! PLEASE!! DO NOT TAKE PROFIT!!! 300% DARK SHORT INTEREST. LET IT RUN!!!!!!!!!!!
0 · Reply
integrityfirst
integrityfirst May. 14 at 9:47 PM
$CPIX PTR 12 is way too low. the company, which is one drug, when phase 3 ready, is worth, to an acquiror 400 mm plus. If accelerated approval worth multiples of that. The people on this board evidence no knowledge of this drug.
0 · Reply
cmeola1066
cmeola1066 May. 14 at 5:06 PM
0 · Reply
haha1978
haha1978 May. 14 at 5:00 PM
$CPIX I can wait for that 3x move. In the mean time enjoy the summer traders. Its vacation time soon.
0 · Reply
haha1978
haha1978 May. 14 at 4:59 PM
$CPIX Dont forget when they sell that 105 million cash and no debt should increase the market cap to 150 to 300 million. Just on standard market cap to equity ratios of 1x to 5x dcepending on industry.
1 · Reply
PrayTradeRepeat
PrayTradeRepeat May. 14 at 4:55 PM
$CPIX Chart is really cleaning up nicely. Consolidating the overhead positions, not selling off. Shorts are covering, SSC data, proxy details send this pre-market to 9.00 before first candle sell off . This is a very exciting HOLD. Low float monster. MM and Darks returning shares, flipping bullish. $GME $AMC vibes. Bring all the trapped $IXHL people and we have a multi day monster.
0 · Reply
haha1978
haha1978 May. 14 at 4:47 PM
$CPIX My dark horse play. Shhhhhhhhh. We are almost at 5.
0 · Reply
Latest News on CPIX
Cumberland Pharmaceuticals Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 9 days ago

Cumberland Pharmaceuticals Earnings Call Transcript: Q1 2026


Cumberland announces launch of new Sancuso website

2026-03-17T13:21:41.000Z - 2 months ago

Cumberland announces launch of new Sancuso website


Cumberland Pharmaceuticals Earnings Call Transcript: Q4 2025

Mar 3, 2026, 4:30 PM EST - 2 months ago

Cumberland Pharmaceuticals Earnings Call Transcript: Q4 2025


Cumberland and THI announce U.S. commercialization of Talicia

2026-02-25T12:20:11.000Z - 2 months ago

Cumberland and THI announce U.S. commercialization of Talicia


Joint U.S. Commercialization of RedHill's Talicia® Commences

Feb 25, 2026, 7:00 AM EST - 2 months ago

Joint U.S. Commercialization of RedHill's Talicia® Commences

RDHL


CUMBERLAND PHARMACEUTICALS LAUNCHES U.S. PROMOTION OF TALICIA®

Feb 25, 2026, 7:00 AM EST - 2 months ago

CUMBERLAND PHARMACEUTICALS LAUNCHES U.S. PROMOTION OF TALICIA®


Cumberland Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 4, 2025, 4:30 PM EST - 6 months ago

Cumberland Pharmaceuticals Earnings Call Transcript: Q3 2025


CUMBERLAND PHARMACEUTICALS ANNOUNCES PRODUCT APPROVAL IN MEXICO

Oct 1, 2025, 9:05 AM EDT - 8 months ago

CUMBERLAND PHARMACEUTICALS ANNOUNCES PRODUCT APPROVAL IN MEXICO


Cumberland Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 10 months ago

Cumberland Pharmaceuticals Earnings Call Transcript: Q2 2025


Cumberland announces partnership with Qureight

2025-05-13T20:22:40.000Z - 1 year ago

Cumberland announces partnership with Qureight


Cumberland Pharmaceuticals Earnings Call Transcript: Q1 2025

May 6, 2025, 4:30 PM EDT - 1 year ago

Cumberland Pharmaceuticals Earnings Call Transcript: Q1 2025


Cumberland Pharmaceuticals Earnings Call Transcript: Q4 2024

Mar 4, 2025, 4:30 PM EST - 1 year ago

Cumberland Pharmaceuticals Earnings Call Transcript: Q4 2024


VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA

Feb 18, 2025, 7:30 AM EST - 1 year ago

VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA


Cumberland announces FDA approves sNDA for Acetadote product

2024-12-09T21:21:06.000Z - 1 year ago

Cumberland announces FDA approves sNDA for Acetadote product


FDA APPROVES ACETADOTE® sNDA

Dec 9, 2024, 4:05 PM EST - 1 year ago

FDA APPROVES ACETADOTE® sNDA


Cumberland Pharmaceuticals Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Cumberland Pharmaceuticals Earnings Call Transcript: Q3 2024


Cumberland Pharmaceuticals Earnings Call Transcript: Q2 2024

Aug 6, 2024, 4:30 PM EDT - 1 year ago

Cumberland Pharmaceuticals Earnings Call Transcript: Q2 2024


Cumberland Pharmaceuticals Earnings Call Transcript: Q1 2024

May 7, 2024, 4:30 PM EDT - 2 years ago

Cumberland Pharmaceuticals Earnings Call Transcript: Q1 2024


Cumberland Pharmaceuticals Earnings Call Transcript: Q4 2023

Mar 5, 2024, 4:30 PM EST - 2 years ago

Cumberland Pharmaceuticals Earnings Call Transcript: Q4 2023


Cumberland Pharmaceuticals Earnings Call Transcript: Q3 2023

Nov 7, 2023, 4:30 PM EST - 2 years ago

Cumberland Pharmaceuticals Earnings Call Transcript: Q3 2023


Cumberland Pharmaceuticals Earnings Call Transcript: Q2 2023

Aug 8, 2023, 4:30 PM EDT - 3 years ago

Cumberland Pharmaceuticals Earnings Call Transcript: Q2 2023


PrayTradeRepeat
PrayTradeRepeat May. 15 at 3:08 PM
$CPIX LET IT SQUEEZE.
0 · Reply
PrayTradeRepeat
PrayTradeRepeat May. 15 at 3:07 PM
0 · Reply
PrayTradeRepeat
PrayTradeRepeat May. 15 at 3:00 PM
$CPIX This does not look like a chart that is collapsing into the holiday weekend right now. What I would personally do in your position: Hold for now Do not add Do not panic dump Stay very focused on VWAP and 5.00 The key is how it behaves if sellers finally show up. If CPIX: loses 5.00 hard cannot reclaim VWAP starts printing expanding red candles with volume Then I would reduce risk quickly because holiday selling could accelerate. But if it: keeps holding 5.09-5.10 keeps squeezing slowly upward stays tight Then the path toward 5.30-5.50 is still alive.
0 · Reply
PrayTradeRepeat
PrayTradeRepeat May. 15 at 2:58 PM
$CPIX H O L D !! PLEASE!! DO NOT TAKE PROFIT!!! 300% DARK SHORT INTEREST. LET IT RUN!!!!!!!!!!!
0 · Reply
integrityfirst
integrityfirst May. 14 at 9:47 PM
$CPIX PTR 12 is way too low. the company, which is one drug, when phase 3 ready, is worth, to an acquiror 400 mm plus. If accelerated approval worth multiples of that. The people on this board evidence no knowledge of this drug.
0 · Reply
cmeola1066
cmeola1066 May. 14 at 5:06 PM
0 · Reply
haha1978
haha1978 May. 14 at 5:00 PM
$CPIX I can wait for that 3x move. In the mean time enjoy the summer traders. Its vacation time soon.
0 · Reply
haha1978
haha1978 May. 14 at 4:59 PM
$CPIX Dont forget when they sell that 105 million cash and no debt should increase the market cap to 150 to 300 million. Just on standard market cap to equity ratios of 1x to 5x dcepending on industry.
1 · Reply
PrayTradeRepeat
PrayTradeRepeat May. 14 at 4:55 PM
$CPIX Chart is really cleaning up nicely. Consolidating the overhead positions, not selling off. Shorts are covering, SSC data, proxy details send this pre-market to 9.00 before first candle sell off . This is a very exciting HOLD. Low float monster. MM and Darks returning shares, flipping bullish. $GME $AMC vibes. Bring all the trapped $IXHL people and we have a multi day monster.
0 · Reply
haha1978
haha1978 May. 14 at 4:47 PM
$CPIX My dark horse play. Shhhhhhhhh. We are almost at 5.
0 · Reply
PrayTradeRepeat
PrayTradeRepeat May. 14 at 2:53 PM
$CPIX Overall catalyst stack ranking: Most immediate: 1 SSc top-line data 2 Proxy filing / shareholder vote date Medium-term: 3. Apotex close 4. DMD regulatory roadmap Longer-term: 5. IPF progression What makes CPIX unusual right now: Normally microcap biotech runs depend on one binary catalyst. CPIX suddenly has multiple overlapping catalysts: • $100M transaction • shareholder vote • biotech transformation narrative • orphan drug pipeline • Fast Track DMD status • upcoming SSc data • low float structure
0 · Reply
PrayTradeRepeat
PrayTradeRepeat May. 14 at 2:52 PM
$IXHL Earnings today? Joel will do a $20M offering. 1. Dreamzzz commencement 2. Horrible Earnings 3. S3 $100M or more ATM $CPIX is clean.
0 · Reply
PrayTradeRepeat
PrayTradeRepeat May. 14 at 3:30 AM
$CPIX Overnight 4.84
0 · Reply
haha1978
haha1978 May. 13 at 10:23 PM
$CPIX We are close to breaking out once we go above 5.10.
1 · Reply
haha1978
haha1978 May. 13 at 10:23 PM
0 · Reply
PrayTradeRepeat
PrayTradeRepeat May. 13 at 2:44 PM
$CPIX DMD stands for Duchenne Muscular Dystrophy. It’s a rare genetic muscle-wasting disease that mostly affects boys. The body cannot properly produce dystrophin, a protein muscles need to protect and repair themselves. Over time, DMD weakens: • skeletal muscles • mobility and walking • breathing muscles • and eventually the heart Many patients later develop cardiomyopathy and heart failure, which is why cardiac-focused drugs matter. CPIX’s drug ifetroban is being studied in DMD because it may help reduce inflammation, fibrosis, and heart damage linked to the disease. Investors are excited because DMD is an orphan disease with: • huge unmet medical need • FDA incentives • possible accelerated approval pathways • and potentially massive commercial value if a therapy works So when traders discuss: • partnerships • buyouts • Phase 3 readiness • or accelerated approval …they’re asking whether ifetroban’s data could become strong enough to attract larger biotech or pharma companies.
0 · Reply
biotechdollars
biotechdollars May. 13 at 1:06 PM
$CPIX frontiere...partnership or buyout depends on how strong DMD data is. Depends on phase 3 trial design. Depends on regulatory pathway, "accelerated approval" ot not. Depends on phase 3 requitements. IF great durable data then buyout, because multiple bidders. If good data, partnership. A phase 3 ready asset, provided phase 3 requirements are not onerous, would attract buyout bids. A buyout is preferred option for shareholders.
1 · Reply
integrityfirst
integrityfirst May. 13 at 12:13 AM
$CPIX PTR SSC tough indication. However Earnings call made reference to "markets" and "populations". If a failure, can at least hope it tended to show anti fibrotic quality. This is not a technical story at this point. CPIX will live or die on its fundamentals. So my advice is to know the fundamentals. Your inquiry suggests you are attempting to do that.
0 · Reply
integrityfirst
integrityfirst May. 13 at 12:08 AM
0 · Reply
PrayTradeRepeat
PrayTradeRepeat May. 12 at 4:23 PM
$CPIX Holds up well against macro with 0.53 beta
0 · Reply
PrayTradeRepeat
PrayTradeRepeat May. 12 at 3:30 PM
$CPIX Supply at 4.65 ?
0 · Reply
haha1978
haha1978 May. 11 at 5:54 AM
$CPIX lets see if we test 5.10s this week.
0 · Reply